S2Medical AB (publ) (STO:S2M)
Sweden · Delayed Price · Currency is SEK 0.0054
0.00 (0.00%)
Sep 24, 2026, 2:01 PM CET
S2Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 14.9 | 14.36 | 14.68 | 6.97 | 4.67 | 7.7 |
Other Revenue | -0 | -0 | - | - | - | - |
| 14.9 | 14.36 | 14.68 | 6.97 | 4.67 | 7.7 | |
Revenue Growth | 2.31% | -2.15% | 110.54% | 49.27% | -39.35% | -70.44% |
Cost of Revenue | 1.72 | 2.09 | 0.77 | 2.69 | 0.99 | 3.54 |
Gross Profit | 13.18 | 12.27 | 13.91 | 4.28 | 3.68 | 4.16 |
Selling, General & Admin | 14.99 | 15.45 | 14.99 | 19.14 | 31.54 | 25.54 |
Other Operating Expenses | -1.07 | -1.79 | -7.22 | -1.33 | -2.1 | -3.03 |
Operating Expenses | 15.11 | 14.94 | 9.08 | 19.55 | 31.36 | 24 |
Operating Income | -1.93 | -2.66 | 4.83 | -15.26 | -27.69 | -19.84 |
Interest Expense | - | -0.01 | -0.02 | -7.44 | -1.77 | -0.24 |
Interest & Investment Income | 0.03 | 0 | 0 | 0 | - | - |
Other Non Operating Income (Expenses) | 0 | 0 | - | - | - | - |
EBT Excluding Unusual Items | -1.9 | -2.67 | 4.81 | -22.71 | -29.46 | -20.08 |
Gain (Loss) on Sale of Investments | -7.42 | -7.42 | - | - | - | - |
Pretax Income | -9.32 | -10.09 | 4.81 | -22.71 | -29.46 | -20.08 |
Net Income | -10.07 | -10.09 | 4.81 | -22.71 | -29.46 | -20.08 |
Net Income to Common | -10.07 | -10.09 | 4.81 | -22.71 | -29.46 | -20.08 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 888 | 857 | 560 | 121 | 24 | 15 |
Shares Outstanding (Diluted) | 888 | 857 | 560 | 121 | 24 | 15 |
Shares Change | 5.58% | 53.03% | 360.86% | 411.02% | 60.30% | 26.41% |
EPS (Basic) | -0.01 | -0.01 | 0.01 | -0.19 | -1.24 | -1.35 |
EPS (Diluted) | -0.01 | -0.01 | 0.01 | -0.19 | -1.24 | -1.35 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.44 | 0.68 | 5.03 | -16.52 | -28.34 | -19.85 |
Free Cash Flow Per Share | -0.00 | 0.00 | 0.01 | -0.14 | -1.19 | -1.34 |
Gross Margin | 88.45% | 85.47% | 94.79% | 61.46% | 78.71% | 54.07% |
Operating Margin | -12.98% | -18.55% | 32.89% | -218.95% | -592.88% | -257.62% |
Profit Margin | -67.61% | -70.28% | 32.78% | -325.73% | -630.73% | -260.78% |
Free Cash Flow Margin | -2.99% | 4.71% | 34.28% | -236.97% | -606.80% | -257.83% |
EBITDA | -1.36 | -2 | 5.52 | -14.14 | -26.37 | -18.73 |
EBITDA Margin | -9.14% | -13.96% | 37.61% | -202.77% | - | -243.22% |
D&A For EBITDA | 0.57 | 0.66 | 0.69 | 1.13 | 1.32 | 1.11 |
EBIT | -1.93 | -2.66 | 4.83 | -15.26 | -27.69 | -19.84 |
EBIT Margin | -12.98% | -18.55% | 32.89% | -218.95% | - | -257.62% |
Revenue as Reported | 16.73 | 16.89 | 22.33 | 8.45 | 8.93 | 11.5 |